Foveal Differentiation and Inner Retinal Displacement Are Arrested in Extremely Premature Infants.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 02 2021
Historique:
entrez: 18 2 2021
pubmed: 19 2 2021
medline: 21 7 2021
Statut: ppublish

Résumé

Children with a history of prematurity often have poorly developed foveae but when during development foveal differences arise. We hypothesize that the course of foveal development is altered from the time of preterm birth. Eyes of 102 preterm infants undergoing retinopathy of prematurity screening examinations in the STudy of Eye imaging in Premature infantS (BabySTEPS) (NCT02887157) were serially imaged between 30 and 42 weeks postmenstrual age (PMA) using handheld optical coherence tomography systems. Total retinal thickness, inner retinal layer (IRL) thickness, and outer retinal layer (ORL) thickness were measured at the foveal center and parafovea. Foveal put depth, IRL thickness, and ORL thickness were compared between infants born at different gestational ages using mixed effects models. Foveal pit depth and IRL thickness were inversely related to gestational age; on average, the most premature infants had the thickest IRL and shallowest pits at all PMAs. Differences were evident by 30 weeks PMA and persisted through 42 weeks PMA. The foveal pits of the most premature infants did not progressively deepen, and the IRLs did not continue to thin with increasing chronological age. Foveation in extremely preterm infants is arrested from the earliest observed ages and fails to progress through term equivalent age. The developmental displacement of the IRL from the foveal center into the parafovea does not occur normally after preterm birth. These observations suggest that foveal hypoplasia seen in children with history of prematurity is due to disturbances in foveal development that manifest within weeks of birth.

Identifiants

pubmed: 33599735
pii: 2772298
doi: 10.1167/iovs.62.2.25
pmc: PMC7900865
doi:

Banques de données

ClinicalTrials.gov
['NCT02887157']

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

25

Subventions

Organisme : NEI NIH HHS
ID : K23 EY028227
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY025009
Pays : United States

Références

Clin Perinatol. 2013 Jun;40(2):271-96
pubmed: 23719310
Ophthalmology. 2011 Aug;118(8):1653-60
pubmed: 21529956
Ophthalmology. 2007 Aug;114(8):1547-51
pubmed: 17337060
Invest Ophthalmol Vis Sci. 2011 Feb 01;52(1):625-34
pubmed: 20861480
Doc Ophthalmol. 2019 Aug;139(1):21-32
pubmed: 30927186
Eye (Lond). 1992;6 ( Pt 2):136-44
pubmed: 1624035
Science. 1982 Jul 16;217(4556):265-7
pubmed: 6178160
Lancet. 2013 Oct 26;382(9902):1445-57
pubmed: 23782686
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):4948-4958
pubmed: 28973368
Am J Ophthalmol. 2012 Nov;154(5):779-789.e2
pubmed: 22898189
Vision Res. 1986;26(6):847-55
pubmed: 3750868
Ophthalmic Physiol Opt. 2015 Jul;35(4):433-41
pubmed: 26094832
Invest Ophthalmol Vis Sci. 2015 Jan 13;56(2):908-13
pubmed: 25587063
Int Ophthalmol. 2019 Jul;39(7):1533-1542
pubmed: 29936688
Retina. 2020 Jul;40(7):1344-1352
pubmed: 31157715
Opt Express. 2010 Aug 30;18(18):19413-28
pubmed: 20940837
Invest Ophthalmol Vis Sci. 2011 Mar 25;52(3):1709-15
pubmed: 21212177
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4537-45
pubmed: 26200492
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
Int Ophthalmol. 2016 Aug;36(4):591-600
pubmed: 26750097
J Med Internet Res. 2020 Jan 30;22(1):e16204
pubmed: 32012066
Invest Ophthalmol Vis Sci. 2014 May 20;55(7):4186-98
pubmed: 24845642
Invest Ophthalmol Vis Sci. 2010 May;51(5):2678-85
pubmed: 20071674
Vision Res. 2010 Apr 7;50(8):810-7
pubmed: 20149815
Biomed Res Int. 2015;2015:782420
pubmed: 26221606
Prog Retin Eye Res. 2018 Sep;66:49-84
pubmed: 29609042
Ophthalmol Retina. 2020 Sep 11;:
pubmed: 32927150
Br J Ophthalmol. 2011 Jun;95(6):799-803
pubmed: 20974631
Biomed Opt Express. 2019 Apr 29;10(5):2623-2638
pubmed: 31143506
Arch Ophthalmol. 2008 Jul;126(7):907-13
pubmed: 18625935
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT69-79
pubmed: 27409508
Ophthalmology. 1984 Jun;91(6):603-12
pubmed: 6462623
Am J Ophthalmol. 2012 Nov;154(5):767-778.e2
pubmed: 22935600
Ophthalmology. 2011 Dec;118(12):2315-25
pubmed: 21940051
Ophthalmology. 2019 Jan;126(1):107-112
pubmed: 30092239
Prog Retin Eye Res. 2013 Jul;35:63-81
pubmed: 23500068
Ophthalmology. 2018 Mar;125(3):444-452
pubmed: 29103792
Eye (Lond). 2020 Jun;34(6):1077-1085
pubmed: 31645674
Invest Ophthalmol Vis Sci. 2008 May;49(5):2061-70
pubmed: 18223243
Arch Ophthalmol. 2012 Oct;130(10):1291-300
pubmed: 23044942
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT235-41
pubmed: 27409477

Auteurs

Matthew L O'Sullivan (ML)

Department of Ophthalmology, Duke University, Durham, North Carolina, United States.
Ophthalmology Residency Program, Duke University, Durham, North Carolina, United States.

Gui-Shuang Ying (GS)

Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, United States.

Shwetha Mangalesh (S)

Department of Ophthalmology, Duke University, Durham, North Carolina, United States.

Vincent Tai (V)

Department of Ophthalmology, Duke University, Durham, North Carolina, United States.

Heena R Divecha (HR)

Department of Ophthalmology, Duke University, Durham, North Carolina, United States.

Katrina P Winter (KP)

Department of Ophthalmology, Duke University, Durham, North Carolina, United States.

Cynthia A Toth (CA)

Department of Ophthalmology, Duke University, Durham, North Carolina, United States.

Xi Chen (X)

Department of Ophthalmology, Duke University, Durham, North Carolina, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH